Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rampling

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|January 1, 1997
Incorporation of iododeoxyuridine in multicellular glioma spheroids: implications for DNA-targeted radiotherapy using Auger electron emittersA Neshasteh-Riz, W J Angerson, J R Reeves, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2004
Updated European core curriculum for radiotherapists (radiation oncologists). Recommended curriculum for the specialist training of medical practitioners in radiotherapy (radiation oncology) within EuropeM Baumann, J W H Leer, O Dahl, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 26, 2011
The concepts, diagnosis and management of early imaging changes after therapy for glioblastomasP Sanghera, R Rampling, B Haylock, et al.
Gene Therapy|April 18, 2002
The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle studyV Papanastassiou, R Rampling, M Fraser, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006
Assessment in vitro of a novel therapeutic strategy for glioma, combining herpes simplex virus HSV1716-mediated oncolysis with gene transfer and targeted radiotherapyM Quigg, R J Mairs, S M Brown, et al.
Gene Therapy|August 31, 2004
HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survivalS Harrow, V Papanastassiou, J Harland, et al.
British Journal of Cancer|September 1, 1996
Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours--evaluation of a potentially effective clinical therapyE A McKie, A R MacLean, A D Lewis, et al.
British Journal of Cancer|June 1, 1986
Antibody-guided irradiation of malignant pleural and pericardial effusionsD Pectasides, S Stewart, N Courtenay-Luck, et al.
British Journal of Cancer|February 24, 1998
Differential cytotoxicity of [123I]IUdR, [125I]IUdR and [131I]IUdR to human glioma cells in monolayer or spheroid culture: effect of proliferative heterogeneity and radiation cross-fireA Neshasteh-Riz, R J Mairs, W J Angerson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of tauromustine in malignant gliomaA Gregor, R Rampling, M Aapro, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|January 1, 1997
Incorporation of iododeoxyuridine in multicellular glioma spheroids: implications for DNA-targeted radiotherapy using Auger electron emittersA Neshasteh-Riz, W J Angerson, J R Reeves, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2004
Updated European core curriculum for radiotherapists (radiation oncologists). Recommended curriculum for the specialist training of medical practitioners in radiotherapy (radiation oncology) within EuropeM Baumann, J W H Leer, O Dahl, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 26, 2011
The concepts, diagnosis and management of early imaging changes after therapy for glioblastomasP Sanghera, R Rampling, B Haylock, et al.
Gene Therapy|April 18, 2002
The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle studyV Papanastassiou, R Rampling, M Fraser, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006
Assessment in vitro of a novel therapeutic strategy for glioma, combining herpes simplex virus HSV1716-mediated oncolysis with gene transfer and targeted radiotherapyM Quigg, R J Mairs, S M Brown, et al.
Gene Therapy|August 31, 2004
HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survivalS Harrow, V Papanastassiou, J Harland, et al.
British Journal of Cancer|September 1, 1996
Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours--evaluation of a potentially effective clinical therapyE A McKie, A R MacLean, A D Lewis, et al.
British Journal of Cancer|June 1, 1986
Antibody-guided irradiation of malignant pleural and pericardial effusionsD Pectasides, S Stewart, N Courtenay-Luck, et al.
British Journal of Cancer|February 24, 1998
Differential cytotoxicity of [123I]IUdR, [125I]IUdR and [131I]IUdR to human glioma cells in monolayer or spheroid culture: effect of proliferative heterogeneity and radiation cross-fireA Neshasteh-Riz, R J Mairs, W J Angerson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of tauromustine in malignant gliomaA Gregor, R Rampling, M Aapro, et al.
Pageof 6